Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
AGIO on Nasdaq
Jacqualyn Fouse - trading volume in the past year for Agios Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common stock |
141K |
$6.88M |
$48.84 |
Jun 13, 2024 |
Direct |
|
|
Restricted stock units |
2.12K |
$104K |
$48.84 |
Jun 20, 2024 |
Direct |
Common stock |
|
Stock options (right to buy) |
11.8K |
|
|
Jun 20, 2024 |
Direct |
Common stock |
|
Performance share units |
0 |
|
$21.64 |
Jan 20, 2024 |
Direct |
Common stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.